Stratec (ETR:SBS) Stock Price Up 5.1% – Should You Buy?

Stratec SE (ETR:SBSGet Free Report)’s share price was up 5.1% during mid-day trading on Friday . The stock traded as high as €35.25 ($37.11) and last traded at €34.15 ($35.95). Approximately 14,984 shares changed hands during trading, an increase of 140% from the average daily volume of 6,253 shares. The stock had previously closed at €32.50 ($34.21).

Stratec Stock Performance

The company has a market capitalization of $415.26 million, a P/E ratio of 28.70, a P/E/G ratio of 10.43 and a beta of 0.16. The company has a debt-to-equity ratio of 65.99, a quick ratio of 1.65 and a current ratio of 2.47. The business’s fifty day simple moving average is €34.27 and its 200-day simple moving average is €40.45.

Stratec Company Profile

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Featured Stories

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.